AI assistant
PROKIDNEY CORP. — Director's Dealing 2024
Apr 16, 2024
32485_dirs_2024-04-16_f55462ae-8d96-4791-8c5c-5a173b0bf526.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PROKIDNEY CORP. (PROK)
CIK: 0001850270
Period of Report: 2024-04-01
Reporting Person: Weber Darin J. (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-04-01 | Class A Ordinary Shares | S | 300 | $1.69 | Disposed | 273773 | Direct |
| 2024-04-12 | Class A Ordinary Shares | S | 84103 | $1.73 | Disposed | 189670 | Direct |
Footnotes
F1: The reported sale of shares occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 20, 2023.
F2: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.69 to $1.77, inclusive. The reporting person undertakes to provide to ProKidney Corp., any security holder of ProKidney Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.